Skip to main content

Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO


Prof. Dr. Arndt Rolfs, Chief Executive Officer of Arcensus GmbH

NEW JERSEY, United States, ROSTOCK, Germany, and BERLIN, Germany – (EMAILWIRE) -- Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of their health is pleased to announce that our Founder, Prof. Dr. Arndt Rolfs, a multi-entrepreneur in biotech and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE, has been appointed as the Chief Executive Officer of Arcensus GmbH.

Prof. Rolfs has succeeded the role from Mr. Michael Schlenk and assumed the responsibilities of CEO on January 01, 2022. We are very grateful for the hard work and dedication of Mr. Schlenk for successfully performing the duties of CEO in 2021 and constructing the organization of Arcensus. We are reassured that Mr. Schlenk will continue supporting Arcensus as an active member of our supervisory board.

Mr Schlenk wished the new CEO every success: "I wish Arndt and the operational team all the best for 2022. There is no doubt that this year will bring great progress for Arcensus after building the company so successfully in a record time. I look forward to supporting the shaping of the business model as a member of the Supervisory Board."

Prof Rolfs is an experienced biotech entrepreneur who knows the necessities and challenges of the healthcare industry very well. Under his leadership, Arcensus will disrupt the genetic diagnostics market through the rapid expansion of its global genomic service and develop new concepts based on genomic knowledge generated worldwide. Arcensus' genomic data already has a diagnostic yield of about 80% in all genetically suspect patients.

Prof Rolfs said: "Our expertise in the high-quality interpretation of Whole Genome DNA Sequencing data reflects the next revolution in modern medicine. Our global genomic knowledge will help pharma partners accelerate the development of new drugs, especially for rare diseases."

About Arcensus

Arcensus is a digital healthcare and diagnostics company that empowers people to take control of their health. The company provides a highest-standard, secure, trusted, and comprehensive medical service based on Whole Genome Sequencing. Arcensus analyses the complete genetic information in human DNA and identifies the predispositions as well as reasons for unclear symptoms with the help of cutting-edge technology including artificial intelligence. The detailed medical report suggests better treatment options and helps individuals take preventive measures to live a healthier and longer life.

From our offices in New Jersey – United States, Rostock and Berlin - Germany, a cross-functional team of genetic experts, medical doctors, and data scientists works to make the most sophisticated and best genetic interpretation with medical and health prevention applications accessible to everyone.

For more information, visit https://arcensus-diagnostics.com/

Important Notice and Disclaimer

This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws. Statements contained herein that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “continues,” “expect,” “estimate,” “intend,” “project,” and similar expressions and future or conditional verbs such as “will,” “would,” “should,” “could,” “might,” “can,” and “may,” are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Arcensus’ actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, negative worldwide economic conditions and ongoing instability and volatility in the worldwide financial markets, the effects of the COVID-19 pandemic on our business and results of operations, possible changes in current and proposed legislation, regulations and governmental policies, pressures from increasing competition and consolidation in our industry, the expense and uncertainty of regulatory approval, including from the U.S. Food and Drug Administration, our reliance on third parties and collaboration partners, including our ability to manage growth and enter into new client relationships, our dependency on the rare disease industry, our ability to manage international expansion, our reliance on key personnel, our reliance on intellectual property protection, fluctuations of our operating results due to the effect of exchange rates, our ability to streamline cash usage, our requirement for additional financing and our ability to continue as a going concern, or other factors.

 

 

Media Contact:

Arcensus GmbH

Awais Bhatti

+49 1525 7692031

marketing@arcensus-diagnostics.com


The press release is issued through EmailWire.Com – a global newswire with press release distribution services.  For more information, go to  https://europenewswire.net/arcensus-has-appointed-prof-dr-arndt-rolfs-as-new-ceo/

 

Comments

Post a Comment

Popular posts from this blog

Ducab to Experience Big Lift in the Power Industry Automation with Accely’s SAP EHS Solution

DUBAI, UAE – ( ARAB NEWSWIRE ) - Accely , a global SAP Gold Partner connected with Tamer Hamed, CIO, Ducab , a power pioneer, to automate its operations and comply with the technologically advanced SAP EHS solution. In the last two decades, Nilesh Shah, CEO, Accely, and his team have empowered businesses across industries worldwide with automated SAP solutions . "It is an immensely great pleasure for Accely to be associated with Ducab, to facilitate the right SAP solution, and strengthen Ducab's system performance. With this SAP solution, it can cope at a faster pace with the changing EHS regulations for the power industry and meet diverse customer demands," said Nilesh Shah. There is an unexpected surge in demand for energy, and Ducab, a leading power firm, realized that this might lead to a decline in energy deliverables. For that reason, the company wanted an intelligent solution that could assist it in automating activities and managing them effectively. Accely...
Post a Comment
Read more

Paula Scher’s First Foray Into Automotive Design: Why the Premium G Series Is the “Only Answer”

   Beijing, China — ( ARAB NEWSWIRE ) — In the high-end off-road world, truly capable vehicles rarely need lengthy introductions. Place them in any environment — their stance, proportions, and lines command attention. Presence becomes identity. That instinctive recognition is often the hallmark of a premium machine, and the G700 is steadily becoming exactly that. Design as Backbone: Crafting the Soul of the G700 What makes the G700 truly impressive isn’t just its GAIA all-terrain intelligent architecture or the brawny hybrid off-road capability. More than that, it reflects a long-term brand commitment that goes beyond hardware. It embeds cultural depth and aesthetic value into the product itself. And the collaboration with world-renowned designer Paula Scher is a defining move — signaling that the G Series is determined to forge a distinctive high-end visual identity through forward-looking design. What the Premium G Series pursues goes beyond building a great v...
Post a Comment
Read more

BingX Expands Global Capital Gala Campaign, Positioning Users for the Next Macro Wave

   PANAMA CITY -- ( ARAB NEWSWIRE ) – BingX , a leading cryptocurrency exchange and Web3-AI company, today announced the launch of the next phase of its Global Capital Gala campaign , offering users new opportunities trading on macro trends and assets, further expanding access to global market opportunities through the BingX ecosystem. Centered around major macroeconomic and market events in May, including U.S. CPI data, nonfarm payrolls, Federal Reserve developments, and NVIDIA earnings, the campaign combines multi-asset trading opportunities with timely market insights designed to help users navigate volatility and position across some of the world’s most closely watched asset classes. Running throughout May, the campaign features a combined prize pool of up to $200,000 across multiple themed trading events spanning crypto, gold, and U.S. equities. Users can participate in trading activities tied to AI, storage, and macro-driven market narratives, while also eng...
Post a Comment
Read more